| News

Sotio opens office in Basel

09.01.2020

The Czech biotech company Sotio has opened an office in the Technologiepark Basel. Sotio Biotech AG will be responsible for the company’s clinical development.

Biotech (img: angellodeco/shutterstock)

BaselArea.swiss has persuaded another company of the benefits of the Basel region. The location promotion organization helped Sotio open an office in the Technologiepark Basel. In a statement, the Czech biotech company cited Basel’s reputation as a top center for life sciences with a global reach as reasons for its choice. Sotio also highlighted Basel’s very attractive business environment and biotechnology talent pool, stating that it plans to add top professionals to its team.

Sotio is part of the PPF Group. Both companies work in cell therapy and are following the strategy to expand their product portfolio to include new immuno-oncology drugs. Sotio Biotech AG will host clinical development in Basel, as well as functions in marketing authorization and commercial launch. With its new office, Sotio is strengthening its presence in globally-recognized biotech hubs, according to Radek Spisek, CEO of SOTIO.

The Czech company has already worked with other companies from Basel, including NBE-Therapeutics and Cellestia Biotech.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
1 2 3 46

Do you have a question? We'd like to hear from you.